Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
01/06/20202:42PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPGNOpGen Inc
12/23/20197:30AMGlobeNewswire Inc.OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Clearance of its Unyvero LRT for BAL SpecimensNASDAQ:OPGNOpGen Inc
12/20/20195:30PMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OPGNOpGen Inc
12/02/20197:30AMGlobeNewswire Inc.OpGen Provides Curetis Group Business Update and Announces Completion of Key Milestones in Planned Business CombinationNASDAQ:OPGNOpGen Inc
11/27/20194:07PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPGNOpGen Inc
11/19/20197:30AMGlobeNewswire Inc.OpGen Products in Development to Address “Urgent Threat” Pathogens Highlighted in New CDC Report on Antibiotic Resistance...NASDAQ:OPGNOpGen Inc
11/14/20194:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
11/13/20193:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
11/12/20196:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
11/12/20195:33PMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OPGNOpGen Inc
11/06/20194:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/06/20194:05PMGlobeNewswire Inc.OpGen Reports Third Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
11/04/20197:30AMGlobeNewswire Inc.OpGen Provides Update on Curetis Group Company Ares Genetics BusinessNASDAQ:OPGNOpGen Inc
11/01/20194:10PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPGNOpGen Inc
11/01/20199:33AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPGNOpGen Inc
10/31/20194:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/29/20194:05PMGlobeNewswire Inc.OpGen Announces Date of Third Quarter 2019 Financial Results Conference CallNASDAQ:OPGNOpGen Inc
10/28/20195:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/28/201911:51AMGlobeNewswire Inc.OpGen Announces Closing of $9.4 Million Underwritten Public OfferingNASDAQ:OPGNOpGen Inc
10/25/20194:59PMEdgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:OPGNOpGen Inc
10/25/20194:59PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OPGNOpGen Inc
10/24/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPGNOpGen Inc
10/23/201911:16PMGlobeNewswire Inc.OpGen Announces Pricing of $9.4 Million Underwritten OfferingNASDAQ:OPGNOpGen Inc
10/23/20197:30AMGlobeNewswire Inc.U.S. Patent Allowed Covering Acuitas Lighthouse® SoftwareNASDAQ:OPGNOpGen Inc
10/18/20195:03PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:OPGNOpGen Inc
10/17/20195:18PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OPGNOpGen Inc
10/15/20196:10AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OPGNOpGen Inc
10/07/20197:30AMGlobeNewswire Inc.OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract InfectionsNASDAQ:OPGNOpGen Inc
09/26/20197:30AMGlobeNewswire Inc.OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019NASDAQ:OPGNOpGen Inc
09/18/20194:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN